Sangam Health Care Products Ltd Files SEBI Compliance Certificate for Q4 FY26
Sangam Health Care Products Ltd submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming proper dematerialization processes. The certificate, signed by Managing Director D. Bhagat Reddy and supported by registrar XL Softech Systems Limited, verifies that securities were properly processed and listed on the stock exchange within regulatory timeframes.
*this image is generated using AI for illustrative purposes only.
Sangam Health Care Products Ltd has filed its quarterly compliance certificate with BSE Limited under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate, submitted on April 15, 2026, addresses the company's adherence to dematerialization procedures and regulatory requirements.
Compliance Certificate Details
The compliance certificate was submitted under Regulation 74(5) of the SEBI regulations, covering the quarter and year ended March 31, 2026. Managing Director D. Bhagat Reddy (DIN: 07087331) signed the certificate on behalf of the company, confirming compliance with dematerialization processes.
| Parameter: | Details |
|---|---|
| Regulation: | SEBI Regulation 74(5) |
| Quarter Ended: | March 31, 2026 |
| Submission Date: | April 15, 2026 |
| BSE Scrip Code: | 531625 |
| Signatory: | D. Bhagat Reddy, Managing Director |
Registrar Confirmation
XL Softech Systems Limited, serving as the company's registrar and transfer agent, provided the underlying confirmation certificate dated April 2, 2026. The registrar confirmed that securities received from depository participants for dematerialization during the quarter ended March 31, 2026 were properly processed and confirmed to the depositories.
The registrar's certificate specifically confirms that:
- Securities received for dematerialization were mutilated and cancelled after due verification
- The name of depositories was substituted in the register of members as registered owners within 30 days
- Securities comprised in the certificates are listed on the stock exchange where earlier issued securities are listed
Regulatory Framework
The compliance certificate references multiple regulatory circulars, including NSDL/CIR/II/5/2019 dated January 25, 2019, CDSL/OPS/RTA/POLCY/2019/14 dated January 25, 2019, and SEBI letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated January 24, 2019. These circulars establish the framework for quarterly compliance reporting by listed companies regarding dematerialization processes.
Corporate Information
Sangam Health Care Products Ltd operates with BSE scrip code 531625. The company maintains its registrar and transfer agent services through XL Softech Systems Limited, based in Hyderabad. The compliance certificate was also copied to Central Depository Services (India) Limited and National Securities Depository Limited, as required under the regulations.
Will Sangam Health Care Products Ltd's consistent regulatory compliance improve its ESG ratings and attract institutional investors in 2026?
How might the company's operational performance in Q1 FY2027 compare to the March 2026 quarter given current healthcare sector trends?
Could Sangam Health Care Products Ltd be considering any strategic partnerships or acquisitions following its strong compliance track record?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
